Data Set CEN/TC 251 prEN 17269 - Concept Medication Summary

Click on triangles in the first column to open/close groups. Click the [-] sign to hide a column. Choose a column with 'Show column' to show it again. You can drag columns to re-arrange the view.

Name	ID[‑]	Datatype[‑]	Description[‑]	Source[‑]	Operationalizations[‑]	Comment[‑]	Status[‑]	Type[‑]	Parent concept[‑]	Inherit from[‑]
Medication Summary	hl7ips-dataelement-16						draft	Group
Medication Summary content status	hl7ips-dataelement-220	Code					draft	Item	Medication Summary
List of medication	hl7ips-dataelement-61						draft	Group	Medication Summary
Medication	hl7ips-dataelement-104						draft	Group	List of medication
Reason	hl7ips-dataelement-226	Collection of data					draft	Item	Medication
Medicinal Product	hl7ips-dataelement-2						draft	Group	Medication
Product Code (Medicinal product Identifier )	hl7ips-dataelement-105	Code	A code identifying the medicine.			To be clarified if at this level we need to distiguish among the different types of "products" : e.g. packaged products; medicinal product; class of products; pharmaceutical products;...	draft	Item	Medicinal Product
Product Common Name (and Strength)	hl7ips-dataelement-171	String					draft	Item	Medicinal Product
Pharmaceutical dose form	hl7ips-dataelement-227	Code	Physical manifestation of a Medicinal Product that contains the active ingredient(s) and/or inactive ingredient(s) that are intended to be delivered to the patient NOTE 1 Dose form, dosage form and pharmaceutical dose form are synonymous. NOTE 2 “Pharmaceutical dose form” can refer to the administered dose form or the manufactured dose form.	EN-ISO IDMP 11615			draft	Item	Medicinal Product
Brand Name	hl7ips-dataelement-117	String					draft	Item	Medicinal Product
Active ingredient List	hl7ips-dataelement-170			CEN/TC 251 prEN 17269:2018 Health informatics — The Patient Summary for Unscheduled Cross-border Care			draft	Group	Medicinal Product
Active Ingredient	hl7ips-dataelement-129						draft	Group	Active ingredient List
Substance code	hl7ips-dataelement-132	Code					draft	Item	Active Ingredient
Strength	hl7ips-dataelement-133	Quantity					draft	Item	Active Ingredient
Administration Instruction	hl7ips-dataelement-222						draft	Group	Medication
Instruction	hl7ips-dataelement-228	Text					draft	Item	Administration Instruction
Period of Medication Use	hl7ips-dataelement-103	Duration	This information may be expressed using start and end date times OR indicating the duration. The first is used to indicate a specified interval (e.g. from March 15th, 2017); the latter for indicating a 'floating' period (e.g. 2 weeks). In case of unbounded period (continuous therapy) the end element will be valued with an exceptional value.				draft	Item	Administration Instruction
Route of administration	hl7ips-dataelement-102	Code					draft	Item	Administration Instruction	hl7ips-dataelement-217
Dose Instruction	hl7ips-dataelement-119						draft	Group	Administration Instruction
Number of units per intake	hl7ips-dataelement-223	Quantity			Range or Quantity		draft	Item	Dose Instruction
Frequency of intake	hl7ips-dataelement-224	Collection of data					draft	Item	Dose Instruction